Basic and Translational Research on Proteinase-Activated Receptors: The Role of Thrombin Receptor in Cerebral Vasospasm in Subarachnoid Hemorrhage
| Autor: | Katsuya Hirano, Hideo Kanaide, Tomio Sasaki, Yasutoshi Kai, Yoshihisa Maeda |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2008 |
| Předmět: |
Subarachnoid hemorrhage
subarachnoid hemorrhage Pharmacology Cerebral vasospasm Thrombin medicine.artery Thrombin receptor medicine Basilar artery Animals Humans Vasospasm Intracranial Protease-activated receptor Receptor PAR-1 proteinase-activated receptor 1 (PAR1) cardiovascular diseases business.industry lcsh:RM1-950 Vasospasm antagonist medicine.disease thrombin nervous system diseases Disease Models Animal lcsh:Therapeutics. Pharmacology Gene Expression Regulation Vasoconstriction Anesthesia Basilar Artery cerebral vasospasm cardiovascular system Molecular Medicine medicine.symptom business medicine.drug circulatory and respiratory physiology |
| Zdroj: | Journal of Pharmacological Sciences, Vol 108, Iss 4, Pp 426-432 (2008) |
| ISSN: | 1347-8613 |
| Popis: | Cerebral vasospasm is one of the major complications of subarachnoid hemorrhage (SAH). The prevention and treatment of cerebral vasospasm thus plays a critical role in the management of SAH patients. However, the mechanism of cerebral vasospasm still remains elusive, while effective therapeutic strategies also remain to be established. The role of thrombin and its receptor proteinase-activated receptor 1 (PAR1) in cerebral vasospasm was investigated using a rabbit double hemorrhage SAH model. The expression of PAR1 was up-regulated and the contractile response to thrombin was markedly enhanced in the basilar artery of SAH models. The intrathecal administration of a PAR1 antagonist prevented the up-regulation of PAR1 and the enhancement of the contractile responses to thrombin in SAH. These observations thus suggest that PAR1 may play a pivotal role in post-hemorrhagic cerebral vasospasm in SAH. Following SAH, thrombin activates PAR1, thereby up-regulating the expression of PAR1, which culminates in the increased contractile response to thrombin in the basilar artery. PAR1 antagonists are thus anticipated to be a novel therapeutic strategy for cerebral vasospasm. However, further studies are needed before establishing the clinical usefulness of PAR1 antagonists. Keywords:: subarachnoid hemorrhage, cerebral vasospasm, thrombin, proteinase-activated receptor, 1 (PAR1), antagonist |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|